These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 21799304)

  • 1. Antagonistic control of muscle cell size by AMPK and mTORC1.
    Mounier R; Lantier L; Leclerc J; Sotiropoulos A; Foretz M; Viollet B
    Cell Cycle; 2011 Aug; 10(16):2640-6. PubMed ID: 21799304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
    White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated maintenance of muscle cell size control by AMP-activated protein kinase.
    Lantier L; Mounier R; Leclerc J; Pende M; Foretz M; Viollet B
    FASEB J; 2010 Sep; 24(9):3555-61. PubMed ID: 20460585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.
    Brockhoff M; Rion N; Chojnowska K; Wiktorowicz T; Eickhorst C; Erne B; Frank S; Angelini C; Furling D; Rüegg MA; Sinnreich M; Castets P
    J Clin Invest; 2017 Feb; 127(2):549-563. PubMed ID: 28067669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells.
    Nakai N; Kawano F; Nakata K
    Mol Cell Biochem; 2015 Aug; 406(1-2):285-92. PubMed ID: 25971373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
    Agarwal S; Bell CM; Rothbart SB; Moran RG
    J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
    Rothbart SB; Racanelli AC; Moran RG
    Cancer Res; 2010 Dec; 70(24):10299-309. PubMed ID: 21159649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.
    Li C; Reif MM; Craige SM; Kant S; Keaney JF
    Nitric Oxide; 2016 May; 55-56():45-53. PubMed ID: 26989010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
    Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
    Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
    Chen MB; Shen WX; Yang Y; Wu XY; Gu JH; Lu PH
    J Cell Physiol; 2011 Jul; 226(7):1915-25. PubMed ID: 21506122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating effect of orotic acid through mTORC1 activation mediated by negative regulation of AMPK in SK-Hep1 hepatocellular carcinoma cells.
    Jung EJ; Lee KY; Lee BH
    J Toxicol Sci; 2012; 37(4):813-21. PubMed ID: 22863860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling.
    Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
    Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
    Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
    Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular brakes regulating mTORC1 activation in skeletal muscle following synergist ablation.
    Hamilton DL; Philp A; MacKenzie MG; Patton A; Towler MC; Gallagher IJ; Bodine SC; Baar K
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(4):E365-73. PubMed ID: 24961241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
    Thomson DM; Fick CA; Gordon SE
    J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.